The Immunohistochemistry Cyclin-D1 Test is a specialized diagnostic procedure used to detect the presence and level of Cyclin-D1 protein in tissue samples. Cyclin-D1 is a crucial protein involved in cell cycle regulation, and its overexpression is often associated with various types of cancers, including breast cancer, mantle cell lymphoma, and multiple myeloma. This test plays a significant role in the diagnosis, prognosis, and sometimes in guiding the treatment strategies for these conditions.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the test involves the application of specific antibodies against Cyclin-D1 on a tissue sample, which is then examined under a microscope. The presence and intensity of staining provide valuable information about the expression levels of Cyclin-D1, helping healthcare professionals make informed decisions about patient care.
The cost of the Immunohistochemistry Cyclin-D1 Test at DNA Labs UAE is 500 AED. The price is reflective of the sophisticated technology and expertise required to accurately conduct the test and interpret the results. Patients seeking this test can expect state-of-the-art services in a patient-centric environment, ensuring high-quality diagnostic care.
The Immunohistochemistry CD7 Test is a specialized diagnostic procedure used to detect the presence of CD7, a protein typically found on the surface of immune cells such as T-cells and natural killer (NK) cells. This test is particularly useful in the diagnosis and classification of certain hematological disorders and lymphoid malignancies, including various types of leukemia and lymphoma. By applying specific antibodies against CD7 on tissue samples, pathologists can visually assess the expression of CD7, aiding in accurate disease identification and treatment planning.
At DNA Labs UAE, the Immunohistochemistry CD7 Test is offered for a cost of 500 AED. The lab is equipped with state-of-the-art facilities and staffed by experienced professionals to ensure high-quality, reliable results. This test is a critical tool in the arsenal of diagnostic procedures, providing essential information for the effective management of patients with suspected or confirmed hematological conditions.
The “Trisomy 8 AML Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect the presence of an extra chromosome 8 in the cells of individuals suspected of having Acute Myeloid Leukemia (AML). This condition, known as Trisomy 8, is a chromosomal abnormality that can contribute to the development and progression of AML, a type of cancer that affects the blood and bone marrow. The test plays a crucial role in the diagnosis, prognosis, and management of AML by providing essential genetic information that can guide treatment decisions. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 1050 AED, ensuring accessibility to crucial diagnostic services for those in need.
Electron Microscopy TEM Test, offered by DNA Labs UAE, is an advanced diagnostic technique that utilizes Transmission Electron Microscopy (TEM) to provide highly detailed images of ultrastructural cell components. This method is pivotal in identifying and analyzing the fine structural details at the molecular level, making it an invaluable tool in research and diagnostic fields, particularly in virology, pathology, and materials science. With a test cost of 1640 AED, DNA Labs UAE ensures accessibility to this sophisticated technology, supporting a wide range of applications from disease diagnosis to the development of new materials. The TEM test at DNA Labs UAE stands as a testament to the integration of cutting-edge technology in enhancing diagnostic accuracy and research capabilities.
The Atypical Hemolytic Uremic Syndrome (aHUS) Panel NGS Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with atypical Hemolytic Uremic Syndrome. aHUS is a rare, life-threatening condition characterized by the triad of hemolytic anemia, thrombocytopenia, and acute kidney failure. This condition is primarily caused by genetic abnormalities that lead to uncontrolled activation of the complement system, an essential part of the immune response.
The test employs Next-Generation Sequencing (NGS) technology, a cutting-edge approach that allows for the simultaneous sequencing of multiple genes to detect mutations with high accuracy. This is crucial for conditions like aHUS, where mutations in several different genes can be responsible for the disease. The panel typically includes genes such as CFH, CFI, CD46 (MCP), C3, and others known to be associated with the disease.
By identifying specific genetic mutations, the aHUS Panel NGS Genetic Test can help in confirming a diagnosis of atypical Hemolytic Uremic Syndrome, guiding treatment decisions, and determining the risk of disease recurrence or familial transmission. This information is invaluable for affected individuals and their families for the management of the condition and for making informed healthcare decisions.
Given the complexity and potential severity of aHUS, the availability of this test at DNA Labs UAE represents a significant advancement in the accessibility of personalized medicine and genetic diagnostics in the region.
